MacroGenics | Resultat Før Skatt

Pre Tax Profit Endring Dato
AbbVie USD 1.76B 4.24B 2024-03
Amgen USD -68000000 3.09B 2024-03
AstraZeneca USD 2.8B 385M 2024-03
Biogen USD 464.8M 336.9M 2024-03
Bristol-Myers Squibb USD -11516000000 15.59B 2024-03
Daiichi Sankyo JPY 97.75B 47.78B 2023-12
Eli Lilly USD 2.54B 52.4M 2024-03
Genmab DKK 1.72B 790M 2024-03
Geron USD -55390000 3.42M 2024-03
Gilead Sciences USD -4486000000 7.08B 2024-03
J&J USD 3.71B 2.52B 2024-03
MacroGenics USD -52190000 6.12M 2024-03
Merck USD 5.67B 6.14B 2024-03
Pfizer USD 3.42B 4.67B 2024-03
Regeneron Pharmaceuticals USD 700.7M 698.9M 2024-03
Roche Holding CHF 10.33B 1.48B 2023-06
Xencor USD -68709000 55.26M 2024-03



MacroGenics Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.